Related references
Note: Only part of the references are listed.In Situ Electrophysiological Examination of Pancreatic α Cells in the Streptozotocin-Induced Diabetes Model, Revealing the Cellular Basis of Glucagon Hypersecretion
Ya-Chi Huang et al.
DIABETES (2013)
Liver-Specific Disruption of the Murine Glucagon Receptor Produces α-Cell Hyperplasia Evidence for a Circulating α-Cell Growth Factor
Christine Longuet et al.
DIABETES (2013)
A Novel, Potent, and Selective Inhibitor of Cardiac Late Sodium Current Suppresses Experimental Arrhythmias
Luiz Belardinelli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells
R. Hage Hassan et al.
DIABETOLOGIA (2012)
Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine
Ryoko Hirakawa et al.
NEUROPHARMACOLOGY (2012)
Glucose Decouples Intracellular Ca2+ Activity from Glucagon Secretion in Mouse Pancreatic Islet Alpha-Cells
Sylvain J. Le Marchand et al.
PLOS ONE (2012)
Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass
Juris J. Meier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes
Jianxin Yang et al.
BMC GENOMICS (2011)
Glucagon as a Critical Factor in the Pathology of Diabetes
Dale S. Edgerton et al.
DIABETES (2011)
Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
Young Lee et al.
DIABETES (2011)
Glucagon antagonism as a potential therapeutic target in type 2 diabetes
J. I. Bagger et al.
DIABETES OBESITY & METABOLISM (2011)
Ranolazine Increases β-Cell Survival and Improves Glucose Homeostasis in Low-Dose Streptozotocin-Induced Diabetes in Mice
Yun Ning et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Membrane Potential-Dependent Inactivation of Voltage-Gated Ion Channels in α-Cells Inhibits Glucagon Secretion From Human Islets
Reshma Ramracheya et al.
DIABETES (2010)
Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome
Jeffrey W. Chisholm et al.
DIABETES CARE (2010)
Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled Trial
David A. Morrow et al.
CIRCULATION (2009)
Incretin-based therapies for type 2 diabetes mellitus
Julie A. Lovshin et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
A KATP channel-dependent pathway within α cells regulates glucagon release from both rodent and human islets of langerhans
Patrick E. MacDonald et al.
PLOS BIOLOGY (2007)
The use of iodixanol for the purification of rat pancreatic islets
H. Delle et al.
TRANSPLANTATION PROCEEDINGS (2007)
Glucagon receptor knockout mice display increased insulin sensitivity and impaired β-cell function
Heidi Sorensen et al.
DIABETES (2006)
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
L. Belardinelli et al.
HEART (2006)
Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells
Sheila Vignali et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Effects of ranolazine on exercise tolerance and HbA(1c) in patients with chronic angina and diabetes
AD Timmis et al.
EUROPEAN HEART JOURNAL (2006)
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina
BR Chaitman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors
KW Sloop et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Glycemic control in mice with targeted disruption of the glucagon receptor gene
JC Parker et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans
KF Petersen et al.
DIABETOLOGIA (2001)
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus
P Shah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Regulation of glucagon release in mouse α-cells by KATP channels and inactivation of TTX-sensitive Na+ channels
SO Göpel et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting α-cells
S Barg et al.
DIABETES (2000)
Share Paper
